RIDGEFIELD, CT, US - Patent application

Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

RIDGEFIELD, CT US

1. 20110046395 PROCESS FOR THE MANUFACTURE OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE 02-24-2011
2. 20110046168 METHODS OF TREATING DISEASES USING QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 02-24-2011
3. 20110046148 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production 02-24-2011
4. 20110046106 ARYL SULFONAMIDES AS EFFECTIVE ANALGESICS 02-24-2011
5. 20110046096 NOVEL PIPERAZINO-DIHYDROTHIENOPYRIMIDINE DERIVATIVES 02-24-2011
6. 20110046087 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF 02-24-2011
7. 20110046076 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF 02-24-2011
8. 20110045531 METHOD FOR PRODUCING A RECOMBINANT PROTEIN ON A MANUFACTURING SCALE 02-24-2011
9. 20110045090 FORMULATIONS OF FLIBANSERIN - pharmaceutical release systems comprising an therapeutically effective amount of flibanserin 02-24-2011
10. 20110041844 NOZZLE AND INHALER AND METHOD FOR PRODUCING A NOZZLE 02-24-2011
11. 20110041840 Atomizing Device, Inhaler and Method for Dispensing a Liquid Formulation 02-24-2011
12. 20110039863 COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS 02-17-2011
13. 20110039851 CCR10 ANTAGONISTS - compound of formula : STR00001 or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein R 02-17-2011
14. 20110038806 MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A STEROID 02-17-2011
15. 20110037978 Miniaturized Confocal Spectrometer - For investigating the spectrum of emission radiation excited in an object by incident radiation, miniaturised 02-17-2011
16. 20110036733 Packaging Material with Desiccant - method for the pretreatment of a desiccant for a package unit for active pharmaceutical ingredient formulations 02-17-2011
17. 20110034512 Indazole Compounds As CCR1 Receptor Antagonists 02-10-2011
18. 20110034444 SELECTED CGRP ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 02-10-2011
19. 20110033870 HYBRIDOMA PRODUCING ANTIBODIES TO LAWSONIA INTRACELLULARIS 02-10-2011
20. 20110033495 METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES 02-10-2011
21. 20110028464 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION 02-03-2011
22. 20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use 02-03-2011
23. 20110028441 NOVEL PHENYL-SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES 02-03-2011
24. 20110022659 Location-Based Networking Methods and Systems for Performing the Same 01-27-2011
25. 20110021550 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation 01-27-2011
26. 20110021501 SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES 01-27-2011
27. 20110021500 NOVEL COMPOUNDS - new CGRP-antagonists of general formula I STR00001 wherein U, V, X, Y, R 01-27-2011
28. 20110021491 COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO 01-27-2011
29. 20110021488 New Compounds - compounds of general formula I STR00001 wherein A, B, D, Y, R 01-27-2011
30. 20110021486 VIRAL POLYMERASE INHIBITORS - Compounds of formula I: STR00001 wherein X, R 01-27-2011
31. 20110020394 PCV2 ORF2 VIRUS LIKE PARTICLE WITH FOREIGN AMINO ACID INSERTION 01-27-2011
32. 20110017205 INHALER - passive inhaler for delivery of a powder-form inhalation formulation from a blister strip with a plurality of blister pockets is proposed 01-27-2011
33. 20110015207 SULFATED BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE RECEPTOR AFFINITY 01-20-2011
34. 20110015203 Viral Polymerase Inhibitors - enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: STR00001 wherein A, B, R 01-20-2011
35. 20110015193 1, 5-DIHYDRO-PYRAZOLO (3, 4-D) PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A MUDULATORS FOR THE TREATMENT OF CNS DISORDERS 01-20-2011
36. 20110015129 NEW PAEDIATRIC INDICATIONS FOR DIRECT THROMBIN INHIBITORS 01-20-2011
37. 20110014284 PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF 01-20-2011
38. 20110014134 SUSPENSION AEROSOL FORMULATIONS OF PHARMACEUTICAL PRODUCTS 01-20-2011
39. 20110011781 APPARATUS FOR THE SEPARATION OF PLASMA - apparatus for separating blood, more particularly an apparatus for absorbing blood and separating blood 01-20-2011
40. 20110005517 ATOMIZER, AND FILTER - Disclosed are an atomizer for a fluid especially for medical aerosol therapy and a filter for said atomizer in order to prevent 01-13-2011
41. 20100331544 METHOD FOR PRODUCING (1R,5S) ANHYDROECGONINE ESTER SALTS 12-30-2010
42. 20100331304 Compounds Which Modulate The CB2 Receptor 12-30-2010
43. 20100331288 CRYSTALLINE HYDRATE OF BETAMIMETIKA AND USE AS MEDICAMENT THEREOF 12-30-2010
44. 20100330186 MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC 12-30-2010
45. 20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity 12-30-2010
46. 20100327476 METHOD AND DEVICE FOR FILLING CAPSULES - method for filling a capsule with a pharmaceutical active-substance formulation 12-30-2010
47. 20100326438 DRY POWDER INHALER - inhaler is proposed which comprises a chamber containing powder 12-30-2010
48. 20100324288 Dihydropteridinone Compounds - Disclosed are new dihydropteridinones of general formula STR00001 wherein the groups L and R 12-23-2010
49. 20100324028 NOVEL COMPOUNDS - new CGRP-antagonists of general formulae Ia and Ib STR00001 wherein R 12-23-2010
50. 20100322870 METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY 12-23-2010
51. 20100322869 METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED SAFETY PROFILE OVER CONVENTIONAL WARFARIN THERAPY 12-23-2010
52. 20100317863 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof 12-16-2010
53. 20100317848 PROCESS FOR THE SYNTHESIS OF DERIVATIVES OF 3-AMINO-TETRAHYDROFURAN-3-CARBOXYLIC ACID AND USE THEREOF AS MEDICAMENTS 12-16-2010
54. 20100317847 CRYSTALLINE FORM OF 4-(BETA-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-- BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS 12-16-2010
55. 20100317669 NOVEL SUBSTITUTED PIPERIDYL-PROPANE-THIOLS 12-16-2010
56. 20100317634 PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS - One object of the present invention are novel substituted piperidyl-propane-thiols of the formula , wherein R 12-16-2010
57. 20100317575 PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE 12-16-2010
58. 20100316818 METHOD FOR STERILIZING A FILM CONTAINER - for holding articles foods cosmetics 12-16-2010
59. 20100316710 SUSTAINED-RELEASE TABLET COMPOSITION OF PRAMIPEXOLE 12-16-2010
60. 20100311985 INDOLINONE DERIVATIVES AND PROCESS FOR THEIR MANUFACTURE 12-09-2010
61. 20100311978 PROCESS FOR OPTIMIZING THE PARTICLE SIZE OF AN ACTIVE PHARMACEUTICAL INGREDIENT BY CRYSTALLIZATION 12-09-2010
62. 20100311721 COMPOUNDS - The present invention encompasses compounds of general formula STR00001 whereinR 12-09-2010
63. 20100311121 REGULATORY NUCLEIC ACID ELEMENTS - DNA-sequences especially transcription- or expression-enhancing elements and their use on an expression vector in 12-09-2010
64. 20100310477 Pharmaceutical compositions based on anticholingerics and additional active ingredients 12-09-2010
65. 20100309510 SYSTEMS, METHODS AND DEVICES FOR PRINTING FROM A MOBILE DEVICE 12-09-2010
66. 20100307494 INHALER - for delivery of a powder-form inhalation formulation from a blister strip with a plurality of blister pockets is proposed 12-09-2010
67. 20100305146 Method for the Production of 1,3-Dioxolane-2-Ones and Carboxylic Acid Esters by Means of Transacylation in Basic Reaction Conditions 12-02-2010
68. 20100305115 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION 12-02-2010
69. 20100305102 HETEROCYCLE-SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES 12-02-2010
70. 20100305099 DIAMINOPYRIDINES FOR THE TREATMENT OF DISEASES WHICH ARE CHARACTERISED BY EXCESSIVE OR ANOMAL CELL PROLIFERATION 12-02-2010
71. 20100298278 INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE 11-25-2010
72. 20100298243 COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS 11-25-2010
73. 20100297697 METHODS FOR INCREASING PROTEIN TITERS - methods of increasing the titre of a protein of interest in a cell as well as the improved production and 11-25-2010
74. 20100297028 MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES 11-25-2010
75. 20100292227 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION 11-18-2010
76. 20100288669 PACKAGING UNIT - having a foldable blank and at least one blister card which can be divided up 11-18-2010
77. 20100286131 VIRAL POLYMERASE INHIBITORS - Compounds of formula I: STR00001 wherein, R 11-11-2010
78. 20100280037 CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE 11-04-2010
79. 20100280028 CXCR3 RECEPTOR ANTAGONISTS - compounds of formula : STR00001 and pharmaceutically acceptable salts thereof, wherein R 11-04-2010
80. 20100278918 EXTENDED RELEASE FORMULATION OF NEVIRAPINE 11-04-2010
81. 20100275917 POWDER INHALER - method a device and a control program for the fluid-tight sealing of capsules containing medicaments 11-04-2010
82. 20100273807 Use of PDE III Inhibitors for the Treatment of Asymptomatic (Occult) Heart Failure 10-28-2010
83. 20100273781 CXCR3 RECEPTOR ANTAGONISTS - compounds of formula : STR00001 and pharmaceutically acceptable salts thereof, wherein R 10-28-2010
84. 20100272759 MODIFIED LIVE VACCINE OF MYCOPLASMA BOVIS, METHODS OF PRODUCING MODIFIED LIVE MYCOPLASMA BOVIS VACCINES, COMBINATION VACCINES AND METHODS OF TREATMENT 10-28-2010
85. 20100272638 RADIOLABELLED MICROPARTICLES, PROCESSES FOR THE PREPARATION THEREOF AND THE USE THEREOF 10-28-2010
86. 20100267960 PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS 10-21-2010
87. 20100267718 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them 10-21-2010
88. 20100266637 METHOD OF PREVENTING EARLY LAWSONIA INTRACELLULARIS INFECTIONS 10-21-2010
89. 20100261714 INHIBITORS OF HIV REPLICATION - Compounds of formula : STR00001 wherein R 10-14-2010
90. 20100261708 Diazepane Compounds Which Modulate The CB2 Receptor 10-14-2010
91. 20100261687 SUBSTITUTED PIPERIDINES AS CCR3 ANTAGONISTS 10-14-2010
92. 20100261677 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS 10-14-2010
93. 20100256188 NEW COMPOUNDS - compounds of general formula I STR00001 in which A, L, M, Q 10-07-2010
94. 20100254939 GRAFT COPOLYMERS AS DRUG DELIVERY SYSTEMS 10-07-2010
95. 20100252949 Process for Preparing Pramipexole Dihydrochloride Tablets 10-07-2010
96. 20100251461 DECORATIVE BAND HAVING AN ADJUSTABLE CIRCUMFERENCE 10-07-2010
97. 20100249458 Process for the manufacture of dihydropteridinones 09-30-2010
98. 20100249412 Process for the manufacture of dihydropteridinones 09-30-2010
99. 20100249392 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture 09-30-2010
100. 20100249158 SUBSTITUTED AMINO-QUINAZOLINONES, MEDICAMENTS COMPRISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE 09-30-2010
101. 20100249114 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 09-30-2010
102. 20100248282 DETECTION OF NO BY USING GUANYLYL CYCLASE AND cGMP PRODUCTION AS A READOUT SYSTEM 09-30-2010
103. 20100242954 SHAPING TOOL HAVING A ROTATABLE BASE MEMBER 09-30-2010
104. 20100242557 Shaping tool having a rotatable base member 09-30-2010
105. 20100240879 PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATES AND INTERMEDIATES THEREIN 09-23-2010
106. 20100240702 Benzimidazolone Chymase Inhibitors - Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving 09-23-2010
107. 20100240669 NEW COMPOUNDS - the compounds of general formula I STR00001 wherein n, R 09-23-2010
108. 20100240657 CHEMICAL COMPOUNDS - The present invention encompasses compounds of general formula wherein the groups R 09-23-2010
109. 20100240069 Drug Discovery Assay for Modulators of HIF-Prolyl Hydroxylase Activity 09-23-2010
110. 20100240065 Prolyl Hydroxylase Compositions and Methods of Use Thereof 09-23-2010
111. 20100234411 New Combination for the Treatment of Respiratory Diseases 09-16-2010
112. 20100234371 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof 09-16-2010
113. 20100234361 SELECTED CGRP-ANTAGONISTS, PROCESS FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 09-16-2010
114. 20100234347 Substituted Pteridines substituted with a Four-Membered Heterocycle 09-16-2010
115. 20100233705 METHOD OR SYSTEM USING BIOMARKERS FOR THE MONITORING OF A TREATMENT 09-16-2010
116. 20100233268 POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS 09-16-2010
117. 20100229857 INHALER DEVICE - hand-held device , as depicted in exemplary FIG 09-16-2010
118. 20100222585 PREPARATION OF DIHYDROTHIENO [3, 2-D] PYRIMIDINES AND INTERMEDIATES USED THEREIN 09-02-2010
119. 20100222336 SINGLE ENANTIOMER BETA-AGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS MEDICATION 09-02-2010
120. 20100222331 NEW COMPOUNDS - The present invention encompasses compounds of general Formula wherein R 09-02-2010
121. 20100220187 OPTICAL MEASUREMENT OF FILL LEVEL - in the aseptic bottling or packaging of biopharmaceuticals 09-02-2010
122. 20100216769 SUBSTITUTED GLYCINAMIDES, PROCESS FOR THEIR MANUFACTURE AND USE THEREOF AS MEDICAMENTS 08-26-2010
123. 20100215590 Micronization Method - method for producing a micronized, virtually anhydrous form of -7-[ 08-26-2010
124. 20100212261 Tight sealing of filled medicament capsules 08-26-2010
125. 20100210845 PROCESS FOR THE PREPARATION OF 4-(BENZIMIDAZOLYLMETHYLAMINO)-BENZAMIDES AND THE SALTS THEREOF 08-19-2010
126. 20100210844 NEW PROCESS FOR THE PRODUCTION OF TIOTROPIUM SALTS 08-19-2010
127. 20100210842 PROCESS FOR PREPARING - method of preparing compounds of general formula I STR00001 wherein m, n, R 08-19-2010
128. 20100210839 SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES 08-19-2010
129. 20100210644 CHEMICAL COMPOUNDS - The present invention encompasses compounds of general formula wherein the groups R 08-19-2010
130. 20100210627 PYRAZINE COMPOUNDS, THEIR USE AND METHODS OF PREPARATION 08-19-2010
131. 20100210595 SUBSTITUTED ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF TYPE I AND II DIABETES MELLITUS 08-19-2010
132. 20100210594 SUBSTITUTED ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF TYPE I AND II DIABETES MELLITUS 08-19-2010
133. 20100209506 PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF 08-19-2010
134. 20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions 08-12-2010
135. 20100204211 MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES 08-12-2010
136. 20100204209 CCR2 Receptor Antagonists and Uses Thereof 08-12-2010
137. 20100204160 SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF 08-12-2010
138. 20100197908 Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds 08-05-2010
139. 20100197719 MEDICAMENT COMPOSITIONS CONTAINING ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND BETAMIMETICS 08-05-2010
140. 20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof 08-05-2010
141. 20100197664 NOVEL B1-ANTAGONISTS - Disclosed are compounds of the formula I STR00001 wherein A, Y, R 08-05-2010
142. 20100197656 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES 08-05-2010
143. 20100196395 ANTI-IGF ANTIBODIES - Antibody molecules in particular fully human antibodies that bind to human IGF-1 and cross-react with IGF-2 such that binding of 08-05-2010
144. 20100192523 Optical Filling Control of Pharmaceutical Capsules in Capsule Filling Machines 08-05-2010
145. 20100190805 PREPARATION FOR THE TREATMENT OF EQUINE LAMINITIS 07-29-2010
146. 20100190779 VIRAL POLYMERASE INHIBITORS - Compounds of formula I: STR00001 wherein X, R 07-29-2010
147. 20100190773 Anti-Cytokine Heterocyclic Compounds - Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein 07-29-2010
148. 20100190767 Compounds for the treatment of inflammatory diseases 07-29-2010
149. 20100189780 Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier 07-29-2010
150. 20100189722 ANTI CD37 ANTIBODIES - Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B 07-29-2010
151. 20100184747 INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER 07-22-2010
152. 20100184729 New Pharmaceutical Compositions for Treatment of Thrombosis 07-22-2010
153. 20100182131 APPARATUS HAVING AT LEAST ONE PACKAGING UNIT WITH AN RFID CHIP WHICH IS USED FOR RADIO-FREQUENCY IDENTIFICATION, AND METHOD THEREFOR 07-22-2010
154. 20100181225 PHARMACEUTICAL BLISTER - new pharmaceutical blister with reduced permeability to water vapor and gas 07-22-2010
155. 20100180211 COMPUTER-BASED METHODS FOR ARRANGING MEETINGS AND SYSTEMS FOR PERFORMING THE SAME 07-15-2010
156. 20100179191 GLUCOPYRANOSYL-SUBSTITUTED CYCLOPROPYLBENZENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AS SGLT INHIBITORS AND PROCESS FOR THEIR MANUFACTURE 07-15-2010
157. 20100178342 Solid Pharmaceutical Preparation - containing one or more solid carriers and/or excipients and an active substance selected from among the Monoamine 07-15-2010
158. 20100178301 METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS 07-15-2010
159. 20100174067 Method for Producing Scopine Esters - novel method for producing scopine esters of the general formula wherein X- 07-08-2010
160. 20100173947 New Indications for Direct Thrombin Inhibitors 07-08-2010
161. 20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions 07-08-2010
162. 20100168191 PHARMACEUTICAL FORMULATION COMPRISING PRAMIPEXOLE 07-01-2010
163. 20100168098 Viral Polymerase Inhibitors - compounds represented by formula wherein A, B, D, E, R 07-01-2010
164. 20100168070 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE 07-01-2010
165. 20100154792 Device For Clamping A Fluidic Component - fluidic component is arranged in an elastomeric shaped part the contour of which is matched to the outer 06-24-2010
166. 20100154072 siRNA Kinase and Methods of Use - finding that Clp1 has the activity of an RNA kinase 06-17-2010
167. 20100152439 PRODUCTION METHOD - process for preparing compounds of general formula I STR00001 wherein R 06-17-2010
168. 20100152244 SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION 06-17-2010
169. 20100152171 CGRP Antagonists - of the formula STR00001 of which the following are exemplary: 4--piperidine-1-carboxyl- ic acid-{-1--2-[4--piperaz- 06-17-2010
170. 20100152167 PYRIMIDINE DERIVATIVES - trisubstituted pyrimidines of formula STR00001 wherein 0R 06-17-2010
171. 20100151530 METHOD FOR PRODUCING PLASMID DNA ON A MANUFACTURING SCALE 06-17-2010
172. 20100150940 ANTI-IGF ANTIBODIES - Antibody molecules in particular fully human antibodies that bind to human IGF-1 and cross-react with IGF-2 such that binding of 06-17-2010
173. 20100145041 Thiazolyl-dihydro-quinazoline compounds and processes for preparing same 06-10-2010
174. 20100144796 NEW POLYMORPHS OF ETHYL 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO- METHYL)-PHENYLAMINO]-METHYL-1-METHYL-1H-BENZIMIDAZOLE-5-CARBONYL) -PYRIDIN-2-YL-AMINO]-PROPIONATE 06-10-2010
175. 20100144784 AEROSOL FORMULATION - propellant-free aerosol formulations for inhalation containing ipratropium bromide and salbutamol 06-10-2010
176. 20100144716 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 06-10-2010
177. 20100144706 Compounds - The present invention encompasses compounds of general formula wherein R 06-10-2010
178. 20100144703 XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 06-10-2010
179. 20100144681 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE 06-10-2010
180. 20100144639 USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) / PROSTATIC HYPERTROPHY 06-10-2010
181. 20100143465 PHARMACEUTICAL COMPOSITION - pharmaceutical tablet or tablet layer comprising the angiotensin II receptor antagonist telmisartan in amorphous form 06-10-2010
182. 20100143331 METHOD FOR MIXING POWDERS - method for preparing powder mixtures, one component consisting of spray-dried powder 06-10-2010
183. 20100137550 Method and Device for Cleaning an Absorptive Polyester 06-03-2010
184. 20100136550 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease 06-03-2010
185. 20100136060 METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS 06-03-2010
186. 20100130557 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS 05-27-2010
187. 20100129398 Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome 05-27-2010
188. 20100129397 EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS 05-27-2010
189. 20100125434 Computer-implemented methods for evaluating, summarizing and presenting data on stability of drug substances and drug products and software-modified computers for such methods 05-20-2010
190. 20100125051 Parenteral Formulations Comprising Sugar-Based Esters and Ethers 05-20-2010
191. 20100121051 UROTENSIN II RECEPTOR ANTAGONISTS - Compounds of the formula STR00001 wherein R 05-13-2010
192. 20100120766 Substituted Pteridines - new pteridines which are suitable for treating respiratory or gastrointestinal complaints or diseases 05-13-2010
193. 20100119506 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation 05-13-2010
194. 20100116268 AQUEOUS AEROSOL PREPARATIONS CONTAINING THERAPEUTICALLY ACTIVE MICRO-ORGANISMS OR PARTS OF MICRO-ORGANISMS AND METHOD FOR PRODUCING CORRESPONDING AEROSOLS 05-13-2010
195. 20100113414 THIAZOLYL-DIHYDRO-INDAZOLES - The present invention encompasses compounds of the general formula STR00001 in whichR 05-06-2010
196. 20100113411 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions 05-06-2010
197. 20100112608 METHOD OF DIAGNOSING LAWSONIA INTRACELLULARIS 05-06-2010
198. 20100107263 C-REACTIVE PROTEIN (CRP) KNOCKOUT MOUSE - The instant invention relates to a transgenic, non-human animal that carries a mutation in the gene encoding 04-29-2010
199. 20100105898 METHOD FOR PRODUCING SCOPINIUM SALTS - new method of preparing scopinium salts of general formula 1 STR00001 wherein Y 04-29-2010
200. 20100104594 PATHOGEN FOR BACTERIAL POULTRY DISEASE - The invention belongs to the field of animal health and in particular the causative agent of a new bacterial 04-29-2010
201. 20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts 04-29-2010
202. 20100099902 CHIRAL PHOSPHANES FOR USE IN ASYMMETRIC SYNTHESES 04-22-2010
203. 20100099882 PROCESS FOR THE PREPARATION OF A BENZIMIDAZOLE DERIVATIVE 04-22-2010
204. 20100099680 PTERIDINONE DERIVATIVES AS P13-KINASES INHIBITORS 04-22-2010
205. 20100099664 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS 04-22-2010
206. 20100099651 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS 04-22-2010
207. 20100099641 CRYSTALLINE FORM OF 1-CHOLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)- -BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS 04-22-2010
208. 20100096408 Apparatus For The Dispensing Of Liquids, Container Cartridge Suitable For This, And System Comprising The Apparatus For The Dispensing Of Liquids And The Container Cartridge 04-22-2010
209. 20100093792 CRYSTALLINE FORMS OF A POTENT HCV INHIBITOR 04-15-2010
210. 20100093754 Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders 04-15-2010
211. 20100093724 Azaindazole Compounds As CCR1 Receptor Antagonists 04-15-2010
212. 20100093703 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS 04-15-2010
213. 20100093654 TETRASUBSTITUTED CLUCOPYRANOSYLATED BENZENE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE 04-15-2010
214. 20100092554 COMBINATION WITH AN EXTENDED RELEASE TABLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 04-15-2010
215. 20100087488 Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester 04-08-2010
216. 20100087382 Inhibitors of Hepatitis C NS3 Protease - Compounds of formula I: STR00001 wherein R 04-08-2010
217. 20100086967 CELL GROWTH - The invention concerns the field of cell culture technology 04-08-2010
218. 20100086947 USE OF FLOW-CYTROMETRIC ANALYSIS TO OPTIMIZE CELL BANKING STRATEGIES FOR CHO CELLS 04-08-2010
219. 20100086589 EXTENDED RELEASE PELLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 04-08-2010
220. 20100082474 Computer method and apparatus that facilitates the trading of complex financial instruments on the internet within the context of a portal as defined by the United States Securities and Exchange Commission 04-01-2010
221. 20100081644 Compounds Which Selectively Modulate The CB2 Receptor 04-01-2010
222. 20100081625 METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISORDERS 04-01-2010
223. 20100076029 Compounds Which Selectively Modulate The CB2 Receptor 03-25-2010
224. 20100074904 SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION 03-25-2010
225. 20100069414 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM 03-18-2010
226. 20100069353 INHIBITORS OF HIV REPLICATION - compounds of formula wherein R 03-18-2010
227. 20100069310 GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZONITRILE DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE 03-18-2010
228. 20100068182 COMBINATION THERAPY FOR TREATING HCV INFECTION 03-18-2010
229. 20100063289 METHOD FOR PRODUCING AMMONIUM HEXAFLUOROPHOSPHATES 03-11-2010
230. 20100063282 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof 03-11-2010
231. 20100063116 USE OF PRAMIPEXOLE OR A SALT THEREOF FOR THE TREATMENT OF PARKINSON'S DISEASE 03-11-2010
232. 20100059051 INHALER - for inhaling a formulation said inhaler comprising a filiform support for metering and/or conveying the formulation 03-11-2010
233. 20100059050 MOUTHPIECE FOR AN INHALER - for administering a drug in the form of substances substance formulations or substance mixtures that can be inhaled 03-11-2010
234. 20100056559 PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION 03-04-2010
235. 20100055193 Stable powder formulation containing an anticholinergic agent 03-04-2010
236. 20100048950 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof 02-25-2010
237. 20100047359 Stable powder formulation containing a novel anticholinergic agent 02-25-2010
238. 20100041898 Electronically Tuned Ligands For Asymmetric Hydrogenation 02-18-2010
239. 20100041649 INHIBITORS OF PAPILLOMA VIRUS - compound of formula or its enantiomers or diastereoisomers thereof: STR00001 wherein: A, X, W, R 02-18-2010
240. 20100041645 RHO KINASE INHIBITORS - Substituted amide and urea derivatives useful as inhibitors of Rho kinase are described which inhibitors can be useful in the 02-18-2010
241. 20100040559 Use of a Pharmaceutical Composition Comprising an Anticholinergic for Killing Microorganisms and for Treating Respiratory Tract Infections 02-18-2010
242. 20100035900 6-Arylmethyl-substituted pyrazolopyrimidines 02-11-2010
243. 20100035889 Use of PDE III Inhibitors For The Treatment of Asymptomatic (Occult) Heart Failure 02-11-2010
244. 20100029644 Compounds Which Modulate The CB2 Receptor 02-04-2010
245. 20100029642 Methods of Using Pyridodihydropyrazinones 02-04-2010
246. 20100029637 Chymase Inhibitors - Disclosed are small molecule inhibitors which are useful in treating various diseases and conditions involving chymase 02-04-2010
247. 20100028860 Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use 02-04-2010
248. 20100028300 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS 02-04-2010
249. 20100024815 PISTON DOSING PUMP - preferably pulverulent formulation to be dosed is received in a dosing chamber having a partly gas-permeable wall 02-04-2010
250. 20100022770 PROCESS FOR THE MANUFACTURING OF BETA MIMETICS 01-28-2010
251. 20100022558 TREATMENT OF INSOMNIA - use of Flibanserin for the preparation of medicaments useful for the treatment of Insomnia 01-28-2010
252. 20100022505 BICYCLIC HETEROCYCLES, DRUGS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR PRODUCTION THEREOF 01-28-2010
253. 20100021911 PRODUCTION HOST CELL LINES - The invention concerns the field of cell culture technology 01-28-2010
254. 20100017249 SYSTEMS AND METHODS FOR ELECTRIC VEHICLE CHARGING AND POWER MANAGEMENT 01-21-2010
255. 20100016449 Formulations with Improved Bioavailability 01-21-2010
256. 20100016310 METHODS OF USING ARYL SULFONYL COMPOUNDS EFFECTIVE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS 01-21-2010
257. 20100015727 METHOD FOR DETERMINING TRANSPORT ACTIVITY OF A TRANSPORT PROTEIN 01-21-2010
258. 20100015061 Pharmaceutical Compositions Based on Anticholinergics and Andolast 01-21-2010
259. 20100010023 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 01-14-2010
260. 20100009984 AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS 01-14-2010
261. 20100009964 Compounds Which Modulate The CB2 Receptor 01-14-2010
262. 20100004228 SELECTED CGRP ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 01-07-2010
263. 20100003278 Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof 01-07-2010
264. 20090326633 CONTROLLED RELEASE ENDOPROSTHETIC DEVICE 12-31-2009
265. 20090326215 GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE 12-31-2009
266. 20090326194 PROCESS FOR PREPARING MACROCYCLIC COMPOUNDS 12-31-2009
267. 20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof 12-31-2009
268. 20090325940 Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof 12-31-2009
269. 20090325926 PYRROLO[3,2-D] PYRIMIDINES AS DPP-IV INHIBITORS FOR THE TREATMENT OF DIABETES MELLITUS 12-31-2009
270. 20090324510 DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES 12-31-2009
271. 20090318547 GLUCOPYRANOSYL-SUBSTITUTED DIFLUOROBENZYL-BENZENE DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE 12-24-2009
272. 20090318480 METHOD FOR TREATING CANCER HARBORING EGFR MUTATIONS 12-24-2009
273. 20090318471 New Salts and Crystalline Salt Forms of an Indolinone Derivative 12-24-2009
274. 20090318469 Use of Flibanserin for the Treatment of Sexual Disorders in Females 12-24-2009
275. 20090318457 Methods of Using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide 12-24-2009
276. 20090317830 HEPATITIS C VIRUS NS2/3 ASSAY - assay for the detection of the NS2/3 cleavage products NS2 or NS3 in the presence of uncleaved NS2/3 12-24-2009
277. 20090317423 PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 12-24-2009
278. 20090317337 AEROSOL FORMULATION FOR INHALATION CONTAINING AN ANTICHOLINERGIC AGENT 12-24-2009
279. 20090312242 FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND RELATED DISEASES 12-17-2009
280. 20090311314 Tiotropium Containing Powder Formulation For Inhalation 12-17-2009
281. 20090308960 DEVICE FOR GRANULATING AND/OR MIXING - in particular for a pharmaceutical active agent formulation comprising a cylindrical granulation chamber that can 12-17-2009
282. 20090306378 PROCESS FOR PREPARING AMINOCROTONYLAMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES 12-10-2009
283. 20090306105 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them 12-10-2009
284. 20090306104 Use of Lck inhibitors for treatment of immunologic diseases 12-10-2009
285. 20090306101 COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS 12-10-2009
286. 20090306072 USE OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PROCESSES 12-10-2009
287. 20090306068 NOVEL ENANTIOMERIC PURE BETA AGONISTS, MANUFACTURING AND USE AS A MEDICAMENTS THEREOF 12-10-2009
288. 20090306067 2, 4-DIAMINOPYRIMIDIDE DERIVATES AND THEIR USE FOR THE TREATMENT OF CANCER 12-10-2009
289. 20090306065 AEROSOL FORMULATION FOR INHALATION CONTAINING AN ANTICHOLINERGIC AGENT 12-10-2009
290. 20090306044 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES 12-10-2009
291. 20090304718 Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them 12-10-2009
292. 20090298840 Hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pterid- inyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament 12-03-2009
293. 20090281153 Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof 11-12-2009
294. 20090280115 Dihydropteridinones in the Treatment of Respiratory Diseases 11-12-2009
295. 20090277446 INHALER - especially a powder inhaler for administering a medicament in the form of inhalable substances 11-12-2009
296. 20090275611 Compounds Which Modulate The CB2 Receptor 11-05-2009
297. 20090264655 PROCESS FOR PREPARING 2,3-DISUBSTITUTED INDOLES 10-22-2009
298. 20090264346 MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS 10-22-2009
299. 20090263861 HOST-VECTOR SYSTEM ANTIBIOTIC-FREE ColE1 PLASMID PROPAGATION 10-22-2009
300. 20090258895 PHARMACEUTICAL FORMULATION AND PROCESS COMPRISING A SOLID DISPERSION OF MACROLIDE (TACROLIMUS) 10-15-2009
301. 20090258857 CHEMICAL COMPOUNDS - The present invention encompasses compounds of general formula wherein R 10-15-2009
302. 20090258856 IMIDAZOPYRIDAZINONE AND IMIDAZOPYRIDONE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 10-15-2009
303. 20090253904 Process for the Preparation of a Tetrahydro-1H-Azepines 10-08-2009
304. 20090253680 SELECTED CGRP-ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 10-08-2009
305. 20090253182 FED-BATCH FERMENTATION PROCESS AND CULTURE MEDIUM FOR THE PRODUCTION OF PLASMID DNA IN E. COLI ON A MANUFACTURING SCALE 10-08-2009
306. 20090253158 Lipoxygenase Enzyme Assay - method for identifying inhibitors of a lipoxygenase enzyme the assay comprising: contacting a lipoxygenase enzyme with a 10-08-2009
307. 20090252790 TABLET FORMULATION - pharmaceutical fixed dose combination tablet comprising repaglinide and metformin 10-08-2009
308. 20090250057 Medicaments magazine for an inhaler, and a multi-dose powder inhaler 10-08-2009
309. 20090247609 SM-PROTEIN BASED SECRETION ENGINEERING - The present invention concerns the field of cell culture technology 10-01-2009
310. 20090247546 Treatment of Prevention of Valvular Heart Disease with Flibanserin 10-01-2009
311. 20090239881 Combinations of Flibanserin with Caffeine, Process for Their Preparation and Use Thereof as Medicaments 09-24-2009
312. 20090239842 Solutions containing epinastin - Topically administered aqueous solutions containing epinastin optionally in the form of its racemate or its enantiomers 09-24-2009
313. 20090238828 Combinations for the Treatment of Diseases involving Cell Proliferation 09-24-2009
314. 20090235929 POWDER INHALERS - powder inhaler for administering moisture-sensitive pharmaceutical formulations 09-24-2009
315. 20090222519 COMPUTER-BASED METHODS FOR ARRANGING MEETINGS AND SYSTEMS FOR PERFORMING THE SAME 09-03-2009
316. 20090221626 AEROSOL FORMULATION FOR INHALATION CONTAINING AN ANTICHOLINERGIC AGENT 09-03-2009
317. 20090221589 Use of aminoalcohol derivatives for the treatment of overactive bladder 09-03-2009
318. 20090215698 LAWSONIA PROTEIN USEFUL AS A COMPONENT IN SUBUNIT VACCINE AND METHODS OF MAKING AND USING THEREOF 08-27-2009
319. 20090209787 METHOD OF PREPARING CHIRAL CYCLIC BETA-AMINOCARBOXAMIDES 08-20-2009
320. 20090209752 DEVICE AND METHOD FOR TREATING OR CLEANING SAMPLE MATERIAL, IN PARTICULAR NUCLEIC ACIDS 08-20-2009
321. 20090203683 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE, AND PROCESSES FOR PREPARING THEM 08-13-2009
322. 20090203673 4-HETEROCYCLOALKYLPYRI(MI)DINES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS 08-13-2009
323. 20090203026 Methods and compositions for targeting secretory lysosomes 08-13-2009
324. 20090202447 INHALANT AEROSOL FORMULATIONS CONTAINING ETHANOL 08-13-2009
325. 20090197876 INDOLINONE DERIVATIVES SUBSTITUTED IN THE 6 POSITION, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS 08-06-2009
326. 20090197841 Inhalant Propellant-Free Aerosol Formulation 08-06-2009
327. 20090194105 INHALER - is proposed , for the inhalation of a formulation from capsules that each contain one dose of the formulation 08-06-2009
328. 20090194099 Nozzle-System For A Dispenser For Fluids consisting Of A Nozzle And A Nozzle-Holder And/or A Screw Cap 08-06-2009
329. 20090192314 PROCESS FOR THE PREPARATION OF CHIRAL 8-(3-AMINOPIPERIDIN-1YL)-XANTHINES 07-30-2009
330. 20090192123 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of Thrombin and/or by elevated expression of Thrombin receptors 07-30-2009
331. 20090186901 CHEMICAL COMPOUNDS - new heterocyclic compounds of general formula wherein the groups R 07-23-2009
332. 20090186881 CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 07-23-2009
333. 20090186875 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES 07-23-2009
334. 20090186010 METHODS FOR THE IDENTIFICATION OF IKKALFA FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES 07-23-2009
335. 20090185983 AQUEOUS MEDICAMENT PREPARATIONS FOR THE PRODUCTION OF PROPELLANT GAS-FREE AEROSOLS 07-23-2009
336. 20090184037 MEMBRANE STRUCTURE FOR GAS SEPARATION - a degassing device having such a membrane structure and also method for production of the same are proposed 07-23-2009
337. 20090182301 DUAL CHAMBER CONTAINER WITHOUT BY-PASS - double chamber container for holding and combining two separate components 07-16-2009
338. 20090181995 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES 07-16-2009
339. 20090181905 CRYSTALLINE FORM OF 1' -(1-METHYLETHYL)-4' -[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5' -METHYL-1H-PYRAZOL-3' -O-BETA-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS 07-16-2009
340. 20090181191 CAPSULE FOR TAKING AN ACTIVE SUBSTANCE WHICH CAN BE INHALED 07-16-2009
341. 20090176807 GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF 07-09-2009
342. 20090176770 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 07-09-2009
343. 20090176698 Benzimidazolone Derivatives for the Treatment of Urinary Incontinence 07-09-2009
344. 20090175802 TIOTROPIUM CONTAINING HFC SOLUTION FORMULATIONS 07-09-2009
345. 20090173345 Medicine Dispensation Device - The invention concerns a medicine dispensation device in particular a multi-dose powder inhalator 07-09-2009
346. 20090171089 1,6 NAPHTHRIDINES USEFUL AS INHIBITORS OF SYK KINASE 07-02-2009
347. 20090170859 Viral Polymerase Inhibitors - enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: STR00001 wherein A, B, R 07-02-2009
348. 20090170839 AEROSOL FORMULATION FOR INHALATION CONTAINING AN ANTICHOLINERGIC AGENT 07-02-2009
349. 20090170815 ALENDRONATE ORAL LIQUID FORMULATIONS - The invention features an oral pharmaceutical solution comprising a therapeutically effective amount of 07-02-2009
350. 20090169622 DELAYED-RELEASE ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COLONIC DISORDERS 07-02-2009
351. 20090165791 INHALER - for administering a medicament in the form of inhalable substances substance formulations 07-02-2009
352. 20090163531 Use of Tiotropium Salts in the Treatment of Severe Persistent Asthma 06-25-2009
353. 20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production 06-25-2009
354. 20090163467 New compounds - The present invention encompasses compounds of general formula STR00001 wherein R 06-25-2009
355. 20090163465 Pyrimidines as PLK inhibitors - The present invention encompasses compounds of general formula STR00001 whereinA W 06-25-2009
356. 20090162900 EXPRESSION VECTOR, METHODS FOR THE PRODUCTION OF HETEROLOGOUS GENE PRODUCTS AND FOR THE SELECTION OF RECOMBINANT CELLS PRODUCING HIGH LEVELS OF SUCH OF SUCH PRODUCTS 06-25-2009
357. 20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS 06-25-2009
358. 20090156822 Hepatitis C Inhibitor Dipeptide Analogs - Compounds of formula : STR00001 wherein R 06-18-2009
359. 20090156554 P13-KINASES - New compounds of formula 1 are provided which by virtue of their pharmaceutical activity as PI3-kinase modulators may be used in the 06-18-2009
360. 20090155185 MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC 06-18-2009
361. 20090149438 Pyrimidines as PLK inhibitors - The present invention encompasses compounds of general formula STR00001 whereinA W 06-11-2009
362. 20090148515 TWO-PIECE METAL CAPSULE FOR ACCOMMODATING PHARMACEUTICAL PREPARATIONS FOR POWDER INHALERS 06-11-2009
363. 20090148474 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME ISOLATES AND METHODS OF USE 06-11-2009
364. 20090146087 Optical Semi-Quantitative 100% Filling Check of Pharmaceutical Capsules on Capsule-filling Machines 06-11-2009
365. 20090143379 Storage stable perfusion solution for dihydropteridinones 06-04-2009
366. 20090143370 Non-nucleoside Reverse Transcriptase Inhibitors 06-04-2009
367. 20090137815 Process for Making Cytokine Inhibiting Compounds Containing 4- and 5-Imidazolyl Rings and the Intermediates Thereof 05-28-2009
368. 20090137801 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 05-28-2009
369. 20090137621 Capsules Containing Inhalable Tiotropium 05-28-2009
370. 20090137578 ENANTIOMERICALLY PURE BETA AGONISTS, PROCESS FOR THE MANUFACTURE THEREOF AND USE THEREOF AS MEDICAMENTS 05-28-2009
371. 20090137545 Compounds - of general formula I STR00001 wherein A, B, D, Y, R 05-28-2009
372. 20090131432 XANTHINE DERIVATES, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS 05-21-2009
373. 20090131424 THIAZOLYL-DIHYDRO-CHINAZOLINE - Disclosed are compounds of general formula , STR00001 wherein the groups A, R 05-21-2009
374. 20090130197 EXTENDED RELEASE PELLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT 05-21-2009
375. 20090130148 MYCOPLASMA BOVIS VACCINE AND METHODS OF USE THEREOF 05-21-2009
376. 20090124809 PROCESS FOR PREPARING ACYCLIC HCV PROTEASE INHIBITORS 05-14-2009
377. 20090124808 PROCESS FOR PREPARING ACYCLIC HCV PROTEASE INHIBITORS 05-14-2009
378. 20090124628 2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments 05-14-2009
379. 20090118511 New method for preparing tiotropium salts 05-07-2009
380. 20090114220 Medicament dispensing device, medicament magazine therefor and method of removing a medicament from a medicament chamber 05-07-2009
381. 20090114215 ATOMIZER AND METHOD OF ATOMIZING FLUID - atomizer and a method of dispensing and atomizing fluid into individual containers through a nozzle are 05-07-2009
382. 20090111838 6-ARYLAMINO-5-CYANO-4-PYRIMIDINONES AS PDE9A INHIBITORS 04-30-2009
383. 20090111797 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 04-30-2009
384. 20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same 04-30-2009
385. 20090110669 METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICES 04-30-2009
386. 20090105236 NEW PHARMACEUTICALLY-ACTIVE COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES 04-23-2009
387. 20090105216 3- (AMINOMETHYLIDEN) 2-INDOLINONE DERIVATES AND THEIR USE AS CELL PROLIFERATION INHIBITORS 04-23-2009
388. 20090104127 SUSPENSION AEROSOL FORMULATIONS OF PHARMACEUTICAL PRODUCTS 04-23-2009
389. 20090101706 Electronic Advertising Device and Method of Using the Same 04-23-2009
390. 20090101145 Medicaments Magazine, and a Device and Method for Opening it; Multi-Dose Powder Inhaler 04-23-2009
391. 20090099225 Method for the production of propellant gas-free aerosols from aqueous medicament preparations 04-16-2009
392. 20090099184 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors 04-16-2009
393. 20090099159 Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds 04-16-2009
394. 20090098202 Extended Release Formulation - The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt 04-16-2009
395. 20090098158 REDUCTION OF CONCOMITANT INFECTIONS IN PIGS BY THE USE OF PCV2 ANTIGEN 04-16-2009
396. 20090093474 THIAZOLYL-DIHYDRO-INDAZOLE - new thiazolyl-dihydro-indazoles of general formula STR00001 wherein the groups R 04-09-2009
397. 20090093457 XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 04-09-2009
398. 20090092636 MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 04-09-2009
399. 20090092559 Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant 04-09-2009
400. 20090092558 MEDICAMENTS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 04-09-2009
401. 20090088571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides 04-02-2009
402. 20090088569 2-AMINO-IMIDAZO[4,5-D]PYRIDAZIN-4-ONES, THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 04-02-2009
403. 20090088408 PHARMACEUTICAL COMPOSITIONS ON ANTICHOLINERGICS, CORTICOSTEROIDS AND BETAMIMETICS 04-02-2009
404. 20090087409 Viral Polymerase Inhibitors - isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: STR00001 wherein:A is O, S, NR 04-02-2009
405. 20090087405 Use of Lck inhibitors for treatment of immunologic diseases 04-02-2009
406. 20090082282 Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure 03-26-2009
407. 20090075990 Aerosol Formulation for Inhalation Containing an Anticholinergic Agent 03-19-2009
408. 20090075949 Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases 03-19-2009
409. 20090069282 ALKYNE COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS 03-12-2009
410. 20090068275 Process for the Manufacture of Powders of Inhalable Medicaments 03-12-2009
411. 20090068223 COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS 03-12-2009
412. 20090054458 USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE 02-26-2009
413. 20090048267 MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES 02-19-2009
414. 20090048231 SUBSTITUTED PROLINAMIDES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS 02-19-2009
415. 20090048173 Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors 02-19-2009
416. 20090042948 Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester 02-12-2009
417. 20090042867 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE 02-12-2009
418. 20090042843 Inhalation Device Containing Plural Doses of a Pharmaceutical Composition 02-12-2009
419. 20090042245 Methods of overexpression and recovery of porcine circovirus type 2 ORF2 02-12-2009
420. 20090041844 Modified Release Formulation - The invention is directed to the use of an extended release tablet formulation for pramipexole 02-12-2009
421. 20090037531 Computer-based networking service and method and system for performing the same 02-05-2009
422. 20090036676 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them 02-05-2009
423. 20090030004 SPECIFIC SALT, ANHYDROUS AND CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE 01-29-2009
424. 20090029990 Dihydropteridinones in the treatment of respiratory diseases 01-29-2009
425. 20090025722 ADAPTER FOR INHALATION APPLIANCES FOR TREATMENT OF ARTIFICIALLY VENTILATED PATIENTS 01-29-2009
426. 20090023920 IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INTERMEDIATES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS AND PESTICIDES 01-22-2009
427. 20090023913 GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE 01-22-2009
428. 20090023712 Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin 01-22-2009
429. 20090023701 Cytokine Inhibitors - Disclosed are compounds of formula STR00001 which inhibit production of cytokines involved in inflammatory processes and are thus 01-22-2009
430. 20090022752 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 01-22-2009
431. 20090022751 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 01-22-2009
432. 20090022750 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 01-22-2009
433. 20090022749 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 01-22-2009
434. 20090022686 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 01-22-2009
435. 20090018333 Dihydropteridione derivatives, process for their manufacture and their use as medicament 01-15-2009
436. 20090018099 PROTEIN PRODUCTION - The invention concerns the field of protein production and cell culture technology 01-15-2009
437. 20090017036 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS 01-15-2009
438. 20090016992 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS 01-15-2009
439. 20090012161 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor 01-08-2009
440. 20090011059 Ginger Extract For Inhibiting Human Drug Transporters 01-08-2009
441. 20090011026 TRANSCORNEAL SYSTEM FOR DELIVERY OF A PHARMACEUTICAL AGENT 01-08-2009
442. 20090010954 PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD 01-08-2009
443. 20080319199 Preparation of Catalysts - novel synthesis method for a catalyst of formula 6, wherein Mes has the meaning of mesityl 12-25-2008
444. 20080319193 New dihydropteridione derivatives, process for their manufacture and their use as medicament 12-25-2008
445. 20080319192 New dihydropteridione derivatives, process for their manufacture and their use as medicament 12-25-2008
446. 20080319190 New dihydropteridione derivatives, process for their manufacture and their use as medicament 12-25-2008
447. 20080319087 Use of Ambroxol for the Treatment of Rhinovirus Infections 12-25-2008
448. 20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta 12-25-2008
449. 20080317766 Costimulatory Molecules and Uses Thereof 12-25-2008
450. 20080312473 Two Step Process for Preparing Substituted Anisidines 12-18-2008
451. 20080312243 IMIDAZOLES AND TRIAZOLES, THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 12-18-2008
452. 20080312210 USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE TREATMENT OR PREVENTION OF HEART FAILURE 12-18-2008
453. 20080312185 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES 12-18-2008
454. 20080305128 TREATMENT OF PRDC IN PIGS - the use of an immunogenic composition comprising a porcine circovirus type 2 antigen for the prevention and treatment 12-11-2008
455. 20080300304 Ginger Fraction For Inhibiting Human Cyp Enzymes 12-04-2008
456. 20080300290 Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments 12-04-2008
457. 20080300207 PROTEIN PRODUCTION - The invention concerns the field of protein production and cell culture technology 12-04-2008
458. 20080299096 MODIFIED NUCLEOTIDE SEQUENCE ENCODING GLUCAGON-LIKE PEPTIDE-1 (GLP-1), NUCLEIC ACID CONSTRUCT COMPRISING SAME FOR PRODUCTION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1), HUMAN CELLS COMPRISING SAID CONSTRUCT AND INSULIN-PRODUCING CONSTRUCTS, AND METHODS OF USE THEREOF 12-04-2008
459. 20080295832 Inhaler with Mouthpiece Having a Microbiological Protective Function 12-04-2008
460. 20080295578 Method for Checking the Permeability Rate of a Closed Container 12-04-2008
461. 20080293972 Process for Preparing Substituted Anisidines 11-27-2008
462. 20080293944 Piperazinyl Compounds - Disclosed are new dihydropteridinones of general formula wherein the groups L and R 11-27-2008
463. 20080293714 Tec Kinase Inhibitors - Disclosed are compounds of formula : wherein Ri, R2, X and Ar are defined herein 11-27-2008
464. 20080293710 Aerosol formulation for the inhalation of beta-agonists 11-27-2008
465. 20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II 11-27-2008
466. 20080292563 Inhalable Powder Containing Tiotropium - powdered preparations containing tiotropium for inhalation processes for preparing them as well as their use in 11-27-2008
467. 20080292562 Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts 11-27-2008
468. 20080287410 PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF PKC-THETA 11-20-2008
469. 20080286259 USE OF ACTIVATED COAGULATION FACTOR VII FOR TREATING THROMBOLYTIC THERAPY-INDUCED MAJOR BLEEDINGS 11-20-2008
470. 20080280904 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors 11-13-2008
471. 20080280897 Aerosol Formulation for Inhalation - propellant-free aerosol formulation which contains one or more compounds of general formula 1 11-13-2008
472. 20080280887 Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions 11-13-2008
473. 20080280840 MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS 11-13-2008
474. 20080279889 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 11-13-2008
475. 20080279876 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 11-13-2008
476. 20080279875 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 11-13-2008
477. 20080279788 Propellant for Dosing Aerosols Comprising Packagings 11-13-2008
478. 20080275011 USE OF DIPYRIDAMOLE, ACETYLSALICYLIC ACID AND AN ANGIOTENSIN II ANTAGONIST FOR TREATMENT AND PREVENTION OF VASCULAR EVENTS 11-06-2008
479. 20080269281 Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs 10-30-2008
480. 20080268470 METHODS OF SELECTING CELL CLONES - The invention describes novel methods for selecting cell clones which produce high amounts of protein of interest 10-30-2008
481. 20080267995 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 10-30-2008
482. 20080262053 Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls) 10-23-2008
483. 20080261975 Tec Kinase Inhibitors - Disclosed are compounds of formula : wherein Q, R 10-23-2008
484. 20080261887 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 10-23-2008
485. 20080260779 USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS 10-23-2008
486. 20080255159 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 10-16-2008
487. 20080255083 NEW PYRIDONE DERIVATES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS 10-16-2008
488. 20080254118 PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS 10-16-2008
489. 20080254117 PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS 10-16-2008
490. 20080254040 COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS OR ANGIOGENESIS 10-16-2008
491. 20080251405 Children's food tray with compartments encouraging artistic or game play 10-16-2008
492. 20080249089 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS 10-09-2008
493. 20080246945 APPARATUS FOR QUANTIFYING SHEAR STRESS ON A FORMULATION COMPRISING BIOMOLECULES 10-09-2008
494. 20080245758 Method And Device For Filling The Dosing Chamber Of An Inhaler For The First Time 10-09-2008
495. 20080242835 Ring-Closing Metathesis Process for the Preparation of Macrocyclic Peptides 10-02-2008
496. 20080242679 Benzimidazolone Derivatives For the Treatment of Premenstrual and Other Female Sexual Disorders 10-02-2008
497. 20080242678 Use of Flibanserin in the Treatment of Obesity 10-02-2008
498. 20080241817 Detection of NO By Using Guanylyl Cyclase and cGMP Production as a Readout System 10-02-2008
499. 20080241190 VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS 10-02-2008
500. 20080241077 BENZOYLGUANIDINE SALT AND HYDRATES THEREOF 10-02-2008
501. 20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions 09-25-2008
502. 20080221159 Inhibitors of human immunodeficiency virus replication 09-11-2008
503. 20080221099 DIHYDROPTERIDINONES FOR THE TREATMENT OF CANCER DISEASES 09-11-2008
504. 20080215374 CLINICAL MANAGEMENT SYSTEM AND METHODS - automated data processing method for obtaining clinical data for safety efficacy and adverse event assessments 09-04-2008
505. 20080207629 LIQUID PREPARATION COMPRISING PIMOBENDAN 08-28-2008
506. 20080200514 Indications for Direct Thrombin Inhibitors 08-21-2008
507. 20080200498 Pharmaceutical Composition For The Treatment Of Disorders Of Sexual Desire 08-21-2008
508. 20080200497 Hepatitis C Inhibitor Peptide Analogs - The compounds of formula I wherein R 08-21-2008
509. 20080199375 Installation and Device for Guiding a Gas for Devices Used to Treat Granular Products by Drying, Film Coating and Coating 08-21-2008
510. 20080197045 Medicament Blister - s for powder inhalers 08-21-2008